EPITHELIOID SARCOMA (EX-US ONLY)

Clinical trials for EPITHELIOID SARCOMA (EX-US ONLY) explained in plain language.

Never miss a new study

Get alerted when new EPITHELIOID SARCOMA (EX-US ONLY) trials appear

Sign up with your email to follow new studies for EPITHELIOID SARCOMA (EX-US ONLY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Experimental drug tazemetostat offered to patients with rare, aggressive tumors

Disease control NO_LONGER_AVAILABLE

This expanded access program provides tazemetostat, a drug that blocks a protein called EZH2, to adults with serious or life-threatening solid tumors that have lost the INI1 or SMARCA4 protein. Eligible patients must have tried other treatments without success and cannot join a f…

Matched conditions: EPITHELIOID SARCOMA (EX-US ONLY)

Sponsor: Epizyme, Inc. • Aim: Disease control

Last updated Jul 03, 2026 20:17 UTC

EPITHELIOID SARCOMA (EX-US ONLY)

Get alerted when new EPITHELIOID SARCOMA (EX-US ONLY) trials appear

Experimental drug tazemetostat offered to patients with rare, aggressive tumors